Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.

Author: KleselN, KortingH C, MaassL, MutschlerE, Schäfer-KortingM

Paper Details 
Original Abstract of the Article :
In gonorrhea therapy, cephalosporins are conventionally administered by intramuscular (i.m.) injection, which rather frequently leads to local side effects. To investigate whether the well-tolerated intravenous (i.v.) injection of cephalosporins may be of comparable gonocidal effect, levels of cefod...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1128/AAC.31.11.1822

データ提供:米国国立医学図書館(NLM)

Cefodizime: A Promising New Cephalosporin for Gonorrhea

Gonorrhea, a sexually transmitted infection, continues to be a significant public health concern. This study investigates the pharmacokinetics of cefodizime, a new broad-spectrum cephalosporin, in healthy volunteers. The researchers compared the levels of cefodizime in serum and skin blister fluid after intravenous and intramuscular injections.

Cefodizime: Effective and Well-Tolerated

The study demonstrates that cefodizime is well-absorbed after both intravenous and intramuscular administrations, reaching effective concentrations in both serum and skin blister fluid. The results suggest that cefodizime could be a promising new treatment option for gonorrhea, offering similar effectiveness with potentially better tolerability compared to other cephalosporins.

Gonorrhea Treatment: Seeking Effective and Safe Solutions

Gonorrhea can have serious consequences if left untreated. It's essential to seek prompt medical attention if you suspect an infection. This study highlights the importance of ongoing research and development of new and effective treatments for sexually transmitted infections.

Dr.Camel's Conclusion

The study's findings offer a glimmer of hope for individuals battling gonorrhea. Just as a camel adapts to its arid environment, researchers are constantly seeking solutions to the challenges posed by infectious diseases. Cefodizime appears to be a promising new weapon in our arsenal against gonorrhea, potentially offering a more effective and well-tolerated treatment option.

Date :
  1. Date Completed 1988-03-11
  2. Date Revised 2021-05-26
Further Info :

Pubmed ID

3435129

DOI: Digital Object Identifier

10.1128/AAC.31.11.1822

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.